A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Pennington Biomedical researchers have contributed to a study highlighting the crucial role of cysteine in regulating ...

Scientists have produced the first detailed characterization of the changes that weight loss causes in human fat tissue by ...

Researchers have mapped human fat tissue at single-cell resolution, uncovering how obesity alters cellular stress, ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...